Recordati SpA (MEX:RECN) Forward Dividend Yield %: 2.81% (As of Jun. 24, 2026)


MEX:RECN Recordati SpA MEX:RECN
71 GF Score
Price MXN1,019.79
GF Value MXN1,150.22
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Recordati SpA Forward Dividend Yield %?

Recordati SpA MEX:RECN 71 Forward Dividend Yield % is 2.81% as of Jun. 24, 2026. GuruFocus rates MEX:RECN with a GF Score™ of 71/100 and a GF Value™ of MXN1,150.22 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 503 Drug Manufacturers companies, Recordati SpA ranks better than 61.23% on this metric.

As of today (2026-06-24), the Forward Annual Dividend Yield of Recordati SpA is 2.81%.

As of today (2026-06-24), the Trailing Annual Dividend Yield of Recordati SpA is 2.72%.

MEX:RECN's Forward Dividend Yield % is ranked better than
61.23% of 503 companies
in the Drug Manufacturers industry
Industry Median: 2.1 vs MEX:RECN: 2.81

Recordati SpA's Dividends per Share for the three months ended in Mar. 2026 was MXN0.00.

During the past 12 months, Recordati SpA's average Dividends Per Share Growth Rate was 5.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 5.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 4.80% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 8.30% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Recordati SpA was 30.20% per year. The lowest was -8.00% per year. And the median was 11.65% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Recordati SpA  (MEX:RECN) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Recordati SpA Forward Dividend Yield % Related Terms


MEX:RECN vs LLY, JNJ, ABBV: Forward Dividend Yield % Comparison

For the Drug Manufacturers - General subindustry, Recordati SpA's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Forward Dividend Yield % falls into.


MEX:RECN
71GF Score
Recordati SpA MEX:RECN
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Recordati SpA Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Recordati SpA Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
EUR 0.7100002026-05-192026-05-192026-05-20Cash Dividendsemi-annuallyEUR:MXN 20.304094
EUR 0.6300002025-11-252025-11-252025-11-26Cash Dividendsemi-annuallyEUR:MXN 21.293988

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Recordati SpA's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=28.83181348/1019.79
=2.83 %

Current Share Price is MXN1019.79.
Recordati SpA's Dividends per Share for the forward twelve months is calculated as MXN14.41590674 * 2 = MXN28.83181348.

Recordati SpA's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=27.83111918/1019.79
=2.73 %

Current Share Price is MXN1019.79.
Recordati SpA's Dividends per Share for the trailing twelve months (TTM) ended in Today is MXN27.83111918.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 2.81% mean?
Recordati SpA (MEX:RECN) has a Forward Dividend Yield % of 2.81% as of Jun. 24, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Recordati SpA and its competitors. According to the industry distribution chart, Recordati SpA ranks #195 out of 503 companies in the Drug Manufacturers industry, placing it in the top 38.8%.
Is Recordati SpA's Forward Dividend Yield % too high?
Recordati SpA's current Forward Dividend Yield % is 2.81%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.10. Recordati SpA's value of 2.81% is 33.8% above this industry median. Based on the distribution chart, Recordati SpA ranks #195 out of 503 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Recordati SpA has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Recordati SpA's Forward Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Recordati SpA ranks #195 out of 503 companies for Forward Dividend Yield %. This puts Recordati SpA in the upper half of its industry. The industry median Forward Dividend Yield % is 2.10. Recordati SpA's value of 2.81% is 33.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.10, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Recordati SpA's current Forward Dividend Yield % of 2.81% is 33.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Recordati SpA and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Recordati SpA's current Forward Dividend Yield % is 2.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Recordati SpA stock overvalued right now?
Based on GuruFocus' analysis, Recordati SpA (MEX:RECN) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,150.22, compared to a current price of MXN1,019.79 — trading 11.3% below its estimated fair value. The current Forward Dividend Yield % is 2.81% and 33.8% above the Drug Manufacturers industry median of 2.10. Recordati SpA's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Recordati SpA (MEX:RECN), the current Forward Dividend Yield % is 2.81% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Recordati SpA (MEX:RECN) Overvalued in 2026?

Based on GuruFocus' analysis, Recordati SpA stock appears to be undervalued. The current stock price of MXN1,019.79 is trading 11.3% below its estimated GF Value™ of MXN1,150.22. GuruFocus considers Recordati SpA to be Modestly Undervalued.

Key valuation signals for MEX:RECN:

  • Forward Dividend Yield %: 2.81%
  • GF Value™: MXN1,150.22 vs. price of MXN1,019.79 (11.3% below fair value)
  • GF Score™: 71/100 with 3 warning signs
  • Industry Position: 33.8% above the Drug Manufacturers median (#195 of 503)

No single metric tells the full story. See the MEX:RECN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Recordati SpA Business Description

Address Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is engaged in the development, production, and marketing of pharmaceutical products or of pharmaceutical chemicals. The Company operates in a broad and diverse context, which includes general medicine, specialist medicine, self-medication, and rare diseases. In addition, it is also active in the field of urology, with treatments for benign prostatic hyperplasia and male functional disorders, and in psychiatry. The Company's only operating segment is the Specialty & Primary Care segment. Its geographic areas are Europe, Australasia, America, and Africa.
71GF Score

Get the complete analysis for MEX:RECN

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,019.79
Price
MXN1,150.22
GF Value